DS-CTN DATA AND SAFETY MONITORING BOARD (DSMB)
LuMind IDSC and the Down Syndrome Clinical Trials Network are pleased to announce the launch…
CapetivateNovember 16, 2022
Report of the Neuroatypical Conditions Expert Consultative Panel
The early detection and accurate diagnosis of Alzheimer’s disease as part of the Affordable Care…
Results From T21RS’s COVID-19 International Survey on Vaccination of Individuals With DS
n a study led by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…
CapetivateJanuary 26, 2022
Five Recent Down Syndrome Research Data Articles to Stay Up to Date
Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related…
CapetivateJanuary 25, 2022
LuMind IDSC Statement on CMS Proposed Coverage for Anti-Amyloid AD Drugs
During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development…
CapetivateJanuary 12, 2022
LuMind IDSC, NDSS and NTG Urge the Advisory Council to Take Action on the Needs of the DS Community
LuMind IDSC, the National Down Syndrome Society (NDSS), and the National Task Group on Intellectual…
CapetivateOctober 20, 2021
LuMind IDSC and Dr. Nicole White Publish “Parental Perspectives on Research for Down Syndrome”
Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts, recently published an…
CapetivateOctober 18, 2021
LuMind IDSC and Team of Experts Publish Article on Aging With DS and the Future of Research
Dr. James Hendrix, LuMind IDSC's Chief Scientific Officer, along with a team of Down syndrome…
CapetivateOctober 13, 2021
Expert Chat: A Conversation with Nicole White
From mom of four to Down syndrome researcher. Community Spotlight sat with Nicole White and…
CapetivateOctober 7, 2021